Intrinsic Edge Capital Management LLC Axogen, Inc. Transaction History

Intrinsic Edge Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$8.38 - $17.34 $2.16 Million - $4.47 Million	-258,003 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$11.18 - $18.6 $1.25 Million - $2.08 Million	-111,563 Reduced 30.19%	258,003 $4.62 Million
Q3 2019 Nov 14, 2019	BUY	$12.09 - $20.46 $4.47 Million - $7.56 Million	369,566 New	369,566 $4.61 Million

163

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $534M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Intrinsic Edge Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Intrinsic Edge Capital Management LLC with notifications on news.